NJPMP & Safer Prescribing
|
|
|
- Rosemary Parrish
- 5 years ago
- Views:
Transcription
1 NJPMP & Safer Prescribing JUNE 12, 2017 Matthew R. Wetzel Acting Administrator, New Jersey Prescription Monitoring Program Assistant Deputy Director, Division of Consumer Affairs
2 Disclosure 2 Mr. Wetzel is the Acting Administrator of the New Jersey Prescription Drug Monitoring Program (NJPMP) and a representative of the State of New Jersey. Any patient or prescriber history that is referenced in this presentation has been de-identified and is used for demonstration purposes only.
3 The Opioid Epidemic Million people misused prescription pain relievers in the past year 1 There was a 200% increase in the number of emergency department visits related to opioid misuse from 2005 to Million people met diagnostic criteria for a substance use disorder in 2015, but ONLY 2.2 Million received treatment National Survey on Drug Use and Health Center for Behavior Health Statistics and Quality Report, SAMHSA
4 NJ Opioid Prescribing Million controlled substances were dispensed in NJ in Nearly 46% were for a narcotic drug In 2016, 36% of narcotic prescriptions dispensed in NJ were for less than a 10 days supply. A decrease of over 7% from 2012 In 2016, over 42% of narcotic prescriptions dispensed in NJ were for greater than a 21 days supply. An increase of almost 9% from 2012
5 NJ Opioid Prescribing 5 Tramadol was scheduled as a Schedule IV in August 2014 Hydrocodone containing products were rescheduled as a Schedule II in October 2014 Prescriptions for Schedule IV narcotic drugs have increased from <1% in 2013 to 15.5% in 2016 Prescriptions for Schedule II narcotic drugs have decreased from 79% in 2013 to 65% in 2016
6 NJPMP Update 6 Platform Change to NJPMP AWARxE (Nov. 2016) newjersey.pmpaware.net Delegates for Prescribers Licensed: Registered Nurse (RN) Licensed Practical Nurse (LPN) Physician Assistant (PA) w/o DEA Advanced Practice Nurse (APN) w/o DEA Dental Hygienist, Registered Dental Assistant Unlicensed: Certified Medical Assistant (CMA)
7 NJPMP AWARxE New Features 7
8 Delegates Add Supervisor (Prescriber) 8 User Profile My Profile No Limit to Number of Supervisors Delegate will need to choose which prescriber they are performing the patient search on behalf of Enter Address of Prescriber (Supervisor)
9 Prescriber- Approve Delegate 9 User Profile Delegate Management Approve a New Delegate Remove an Active Delegate
10 Bulk Patient Search 10 RxSearch Bulk Patient Search
11 Bulk Patient Search 11 RxSearch Bulk Patient Search User defined search name
12 NJPMP Data Sharing 12 NJPMP Shares controlled substance prescription data with the following states: Recently Added: Pennsylvania Massachusetts New Hampshire Maine West Virginia Existing States: New York Connecticut Delaware Rhode Island Virginia South Carolina Minnesota
13 Setting Default PMPi States 13 User Profile Default PMPi States
14 Morphine Milligram Equivalent (MME) 14 RxSearch Patient Request Summary: Active Daily MME value Prescription: Daily MME value for each prescription Use CDC Conversion Factor
15 MME Conversion 15 Factor (CDC) CDC Guideline for Prescribing Opioids for Chronic Pain
16 Prescriber Self-Lookup (MyRx) 16 RxSearch MyRx Displays all patient prescriptions dispensed under your DEA Number Periodically review your prescription history Patient Compliance Unauthorized Prescriptions
17 A Prescriber s Prescription History Total Prescriptions 26 Cash 35 Insurance 2 Medicaid/Medicare 51 Different Patients 21 Under Age Between Over Age Different Pharmacies De-Identified Rx Fill Date Patient Drug Name Qty Days Payment Type Supply KESI 11/17/2014 OXYCODONE HCL 30 MG TABLET Insurance AGLU 11/18/2014 OXYCODONE HCL 30 MG TABLET Cash DANO 11/19/2014 OXYCODONE HCL 30 MG TABLET Cash SHSE 11/20/2014 OXYCODONE HCL 30 MG TABLET Insurance ARNE 11/20/2014 OXYCODONE HCL 30 MG TABLET Insurance BRDR 11/20/2014 OXYCODONE HCL 30 MG TABLET Medicaid JONA 11/24/2014 OXYCODONE HCL 30 MG TABLET Cash PAIH 11/24/2014 OXYCODONE HCL 30 MG TABLET Insurance STSE 11/24/2014 OXYCODONE HCL 30 MG TABLET Cash CLSE 11/24/2014 OXYCODONE HCL 30 MG TABLET Cash JASE 11/24/2014 OXYCODONE HCL 30 MG TABLET Cash MIAR 11/24/2014 OXYCODONE HCL 30 MG TABLET Insurance MAAH 11/24/2014 OXYCODONE HCL 30 MG TABLET Cash DAON 11/24/2014 OXYCODONE HCL 30 MG TABLET Cash ANNO 11/25/2014 OXYCODONE HCL 30 MG TABLET Cash MIYE 11/25/2014 OXYCODONE HCL 30 MG TABLET Cash RIRO 11/25/2014 OXYCODONE HCL 30 MG TABLET Cash UNNO 11/26/2014 OXYCODONE HCL 30 MG TABLET Cash KASE 11/26/2014 OXYCODONE HCL 30 MG TABLET Insurance ASNI 11/26/2014 OXYCODONE HCL 30 MG TABLET Insurance
18 Review Your Prescription History 18 Doctor is an Anesthesiologist Never wrote prescriptions for controlled substances Doctor s DEA number was stolen All 63 prescriptions were written and filled in a 30 day time period Doctor discovered the issue when he used the prescriber self-lookup report Reported to the NJ Drug Control Unit and NJPMP
19 Safer Prescribing 19 E-Prescribing of Controlled Substances (EPCS) Periodic review of your prescription history Notify a pharmacy if a patient s prescription is incorrect Utilize delegate(s) to obtain a patient s NJPMP report Quarterly review of patients NJPMP report if on an opioid therapy for extended period of time
20 Informational Resources 20 NJPMP Prescribing for Pain FAQs and information on the new 5 day prescribing law Project Medicine Drop Safe disposal of controlled substance medications Drug Control Unit EPCS information
21 21 Contact the NJPMP Matthew Wetzel, Acting Administrator If you have questions or issues, please the NJPMP at: Or call:
April 26, New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) New Mexico Nurse Practitioner Council New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) Peter Ryba, PharmD PMP Director
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Arizona Amends worker s compensation statute to require physicians to request PMP information within two (2) business days of writing or dispensing prescriptions for at least a 30 day supply of an opioid
Pennsylvania Prescription Drug Monitoring Program Trends,
DEA Intelligence Report Brief DEA-PHL-DIR-006-17 Pennsylvania Prescription Drug Monitoring Program Trends, 2014-2015 December 2016 1 Executive Summary The abuse and diversion of pharmaceutical drugs, particularly
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alaska Requires adoption of regulations that provide that a practitioner query the PDMP prior to dispensing, prescribing, or administering a Sch. II or III controlled substance; query is not required for
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP)
New Mexico Board of Pharmacy Prescription Monitoring Program (PMP) PDMP West Regional Meeting PMP Collaboration with the NM Department of Health April 26, 2018 New Mexico Board of Pharmacy Prescription
Shannon Whitman Program Administrator Advancing Use of the MN PMP
Shannon Whitman Program Administrator Advancing Use of the MN PMP TODAY S OBJECTIVE What is a PMP/PDMP, why do we need one? What is the national status of PMPs? Minnesota s intent of the PMP What does
State, District, or Territory Criteria for Mandatory Enrol ment or Query of PDMP
State, District, or Territory Alabama Arizona Arkansas Criteria for Mandatory Enrollment or Query of PDMP Before renewing an Alabama Controlled Substances Certificate, the applicant shall have a current
The Oregon Opioid Initiative. State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division
The Oregon Opioid Initiative State Pain & Opioid Conference Prescription Drug Monitoring May 2018 Lisa Millet, Public Health Division Disclosure No disclosures 2 Learning Objectives Learner will be able
Prescription Drug Monitoring Program (PDMP)
Prescription Drug Monitoring Program (PDMP) District of Columbia Information contained in this presentation is accurate as of September 2017 Meet the Speaker Tadessa Harper-Nichols Program Specialist Pharmaceutical
The Wisconsin Prescription Drug Monitoring Program
The Wisconsin Prescription Drug Monitoring Program DHS 2018 WI Opioid Forum April 12, 2018 Learning Objectives 1. How the WI epdmp supports healthcare professionals in making informed prescribing, dispensing
The Wisconsin Prescription Drug Monitoring Program. WI PDMP Timeline. PDMP Overview. What is a PDMP? PDMPs Across the Nation. Wisconsin.
The Wisconsin Prescription Drug Monitoring Program Wisconsin Nurses Association Jail Health Care Conference May 21, 2018 WI PDMP Timeline PDMP Overview January 2013 WI PDMP operational April 2017 WI epdmp
Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD
Harold Rogers Prescription Drug Monitoring Program Regional Meeting-Charleston, SC April 29, 2014 Andrew Holt, PharmD National Epidemic Highlighted numerous studies/media reports State Epidemic Highlighted
The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin Epidemic in our Country
Integrating Primary and Behavioral Health Care Through the Lens of Prevention July 14, 2016 New Orleans, Louisiana The Future of Prevention: Addressing the Prescription Drug Abuse and the Opioid/Heroin
4/26/2018. Bureau of Professional Licensing. MAPS Updates & Opportunities. MAPS Background. Registration. MAPS Update
Bureau of Professional Licensing MAPS Updates & Opportunities April 28, 2018 Presented by Andrew Hudson, Manager Haley Winans, Analyst Drug Monitoring Section Bureau of Professional Licensing BPL-MAPS@Michigan.gov
D. Todd Bess, PharmD 1
s Program as a Tool to Improve Patient Care and Fight the Drug Epidemic D. Todd Bess, Pharm.D. Director April 12, 2018 Disclosure Information I have no financial relationships to disclose. I will not discuss
Mandatory PDMP Use PDMP Use STATE Prescriber Dispenser Conditions, if applicable
Alabama Requirements for use of the PMP, including the following: 1) when prescribing a patient a controlled substance of more than 30 MME per day, physicians shall query the PMP for that patient at least
SCRIPTS. South Carolina Reporting & Identification Prescription Tracking System
SCRIPTS South Carolina Reporting & Identification Prescription Tracking System Accidental Deaths 3 Due to Drug Overdose SC Occurrence Data Accidental Drug Overdose Year # of Deaths All deaths Drug not
Greenbrier County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
Opioid Deaths Quadruple Since 1999
THE COUNCIL OF STATE GOVERNMENTS CAPITOL RESEARCH AUGUST 2017 HEALTH POLICY Opioid Deaths Quadruple Since 1999 Since 1999, the number of overdose deaths involving opioids (including prescription opioids
States with Authority to Require Nonresident Pharmacies to Report to PMP
States with Authority to Require Nonresident Pharmacies to Report to PMP Research current through May 2016. This project was supported by Grant No. G1599ONDCP03A, awarded by the Office of National Drug
C U S T O M E R D R I V E N. B U S I N E S S M I N D E D.
MAPS Update May 4, 2018 Presented by Kim Gaedeke, Acting Deputy Director Department of Licensing and Regulatory Affairs Andrew Hudson, Manager Drug Monitoring Section BPL-MAPS@Michigan.gov 517-373-1737
Arkansas Department of Health
Arkansas Department of Health 4815 West Markham Street Little Rock, Arkansas 72205-3867 Telephone (501) 661-2000 Governor Mike Beebe Nathaniel Smith, MD, MPH, Interim Director and State Health Officer
ACCG Mental Health Summit
ACCG Mental Health Summit Sheila Pierce, Opioid Program Coordinator Director, Prescription Drug Management Program Discussion 1. Overview Opioid Problem in GA - Video 2. DPH Opioid Program 3. Priorities
Arkansas Prescription Monitoring Program
Arkansas Prescription Monitoring Program ONE YEAR UPDATE Scott Pace, Pharm.D., Esq. Special Thanks Thanks to Denise Robertson at the Arkansas Department of Health for supplying the PMP data for this presentation
& CONSUMES 80% 5% OF THE WORLD S POPULATION 5/19/2017. New Naloxone Regulations & the Importance of Using PRESCRIPTION DRUG ABUSE EPIDEMIC
New Naloxone Regulations & the Importance of Using the PMP Yenh Long PharmD, BCACP Program Administrator Nevada Prescription Monitoring Program May 17, 2017 PRESCRIPTION DRUG ABUSE EPIDEMIC The United
Curbing Prescription Drug Abuse in Medicaid
Curbing Prescription Drug Abuse in Medicaid Joint Legislative Health Care Oversight Committee October 12, 2010 Dr. Lisa Weeks, BSPharm, PharmD Pharmacy and Ancillary Services Division of Medical Assistance
Barbour County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report Barbour County
County West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report County The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with
Prescription Monitoring Program Center for Excellence, Brandeis University. April 10-12, 2012 Walt Disney World Swan Resort
Prescription Monitoring Program Center for Excellence, Brandeis University April 10-12, 2012 Walt Disney World Swan Resort Accepted Learning Objectives: 1. Explain the current capabilities and contributions
A Bill Regular Session, 2015 SENATE BILL 717
Stricken language would be deleted from and underlined language would be added to present law. 0 State of Arkansas 0th General Assembly As Engrossed: S// H// A Bill Regular Session, SENATE BILL By: Senator
Mingo County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
Putnam County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
Policy and Political Dynamics of the Opioid Addiction Crisis in the United States
Policy and Political Dynamics of the Opioid Addiction Crisis in the United States Mark W. Parrino, M.P.A. July 21, 2018 15 th Annual Midwest Conference on Problem Gambling and Substance Abuse Hilton Kansas
Pocahontas County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
Kanawha County. West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators County Report
West Virginia Board of Pharmacy Prescription Opioid Problematic Prescribing Indicators Report The West Virginia Violence and Injury Prevention Program ( VIPP), in collaboration with the West Virginia Board
Prescription Drug Monitoring Program (PDMP) Delaware. Information contained in this presentation is accurate as of November 2017
Prescription Drug Monitoring Program (PDMP) Delaware Information contained in this presentation is accurate as of November 2017 Dr. Michael C. Dejos, PharmD, BCPS, LSSBB 2 Acknowledgements Christian Ruffin,
Prescription Monitoring Program (PMP)
06/15/2018 FACT SHEET Implementation of Enacted Prescribing Limits and Requirements and Relevant Opioid Prescribing Laws and Rules Background: The 2016 law (Chapter 488) makes five major changes to opioid
Prescription Drug Monitoring Program Update. Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017
Prescription Drug Monitoring Program Update Rebecca R. Poston, BPharm., MHL Program Manager August 26, 2017 Objectives Brief historical overview of opioids Review of PDMP information Discuss ideas from
Blue Cross of Idaho Addresses State s Opioid Issue
Blue Cross of Idaho Addresses State s Opioid Issue BY THE NUMBERS - Opioid Management page 3 THE PROBLEM - How Preventing Pain Hurt Us page 4 THE SOLUTIONS - Idaho State Board Of Pharmacy Prescription
State, District, or Territory Criteria for Mandatory Query of PDMP
State, District, or Territory Alabama Alaska Arizona Criteria for Mandatory Query of PDMP Requirements for use of the PMP, including the following: 1) when prescribing a patient a controlled substance
The Epidemiology of Opioid Abuse. Thomas Dobbs, MD, MPH Mississippi State Department of Health
The Epidemiology of Opioid Abuse Thomas Dobbs, MD, MPH Mississippi State Department of Health 1/12/2018 ACKNOWLEDGEMENTS DRUG ABUSE WORKING GROUP MISSISSIPPI STATE DEPARTMENT OF HEALTH Manuela Staneva,
Treating pain without pills
Treating pain without pills Treating pain without pills HealthPartners pain management program Nearly one-third of Americans experience pain. Pain medication is the most commonly prescribed class of drugs
Opioid Use and Other Trends
Opioid Use and Other Trends National Overview Across the nation communities are struggling with a devastating increase in the number of people misusing opioid drugs, leading many to identify the current
Opioid Abuse and Prescribing. Dr. Mitchell Mutter Director of Special Projects
Opioid Abuse and Prescribing Dr. Mitchell Mutter Director of Special Projects Auburn University February 22, 2019 Disclosure Statement of Financial Interest I, Mitchell Mutter, DO NOT have a financial
4/24/15. New Mexico s Prescription Monitoring Program. Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy. New Mexico and the PMP
New Mexico s Carl Flansbaum, RPh. PMP Director New Mexico Board of Pharmacy New Mexico and the PMP In 2012, New Mexico had the 3 nd Highest Overdose Death Rate in Nation.! 492 Deaths or a rate of 23.6
PDMP Tools to Identify Red Flag Situations
PDMP Tools to Identify Red Flag Situations Prescription Drug Monitoring Programs CBI Baltimore, MD February 7, 2017 Grant Carrow, Ph.D. Project Consultant The Heller School for Social Policy and Management
Opioid Management of Chronic (Non- Cancer) Pain
Optima Health Opioid Management of Chronic (Non- Cancer) Pain Guideline History Original Approve Date 5/08 Review/Revise Dates 11/09, 9/11, 9/13, 09/15, 9/17 Next Review Date 9/19 These Guidelines are
Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science
Interstate Variation in Prescribing of Opioid Pain Relievers and Benzodiazepines Karin A. Mack, PhD Associate Director for Science National Center for Injury Prevention and Control Division of Analysis,
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 2017 (2017Q4)
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT FOURTH QUARTER OF 217 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau
www.njconsumeraffairs.gov 1 New Jersey Prescription Monitoring Program (NJPMP) James Mielo, Administrator, NJPMP New Jersey Division of Consumer Affairs 2 The Challenge of Staying Relevant 3 2000- We need
Prescription Drug Monitoring Program
California Department of Justice Prescription Drug Monitoring Program May, 2016 Health and Safety Code section 11165. (a) To assist health care practitioners in their efforts to ensure appropriate prescribing,
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2018 (2018Q3)
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 218 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau
Strategies to Manage The Opioid Crisis
Strategies to Manage The Opioid Crisis Matt Feehery, LCDC Senior Vice President & CEO PaRC (Prevention & Recovery Center) Behavioral Health Services February 1, 2018 A Pill for Your Pain But my doctor
Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York
Preparing for Electronic Prescribing of Controlled Substances (EPCS) in New York Ken Whittemore, Jr. R.Ph., MBA Senior VP, Professional & Regulatory Affairs Copyright Copyright 2015 by 2015 Surescripts,
Opioid Report Card. opioid oversight from MN Dept of Health
Opioid Report Card opioid oversight from MN Dept of Health Charles Reznikoff, MD Addiction Medicine, Internal Medicine Charles.reznikoff@hcmed.org Nov 2018 Disclosures I have no relevant financial disclosures
If you suspect Fido's owner is diverting prescription pain meds meant for the pet, checking your state's drug monitoring database may not help
Prescriptions If you suspect Fido's owner is diverting prescription pain meds meant for the pet, checking your state's drug monitoring database may not help by Ann M. Philbrick, PharmD, BCPS The Centers
Public Health Federal Funding Request to Address the Opioid Epidemic
Public Health Federal Funding Request to Address the Opioid Epidemic On December 4, 2017, in response to the President s recent declaration of the opioid epidemic as a public health emergency and the final
WHAT YOU NEED TO KNOW TO ABOUT AB 474
WHAT YOU NEED TO KNOW TO ABOUT AB 474 PRESENTED BY: NEVADA STATE BOARD OF OSTEOPATHIC MEDICINE 2275 Corporate Circle, Suite 210 Henderson, NV 89074 702-732-2147 Fax 702-732-2079 Web Site: www.bom.nv.gov
Medicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Anthem Blue Cross and Blue Shield Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain management.
Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015
Wisconsin Statewide Substance Abuse Prevention Training Wisconsin Dells June 12, 2015 1 Presenter Andrea Magermans Program Analyst of the Wisconsin PDMP Wisconsin Department of Safety and Professional
Kentucky All Schedule Prescription Electronic Reporting (KASPER)
Kentucky All Schedule Prescription Electronic Reporting (KASPER) Phyllis Millspaugh Manager, Behavioral Health Prevention and Promotion Kentucky Cabinet for Health and Family Services Using PDMP Data to
PRESCRIPTION DRUG MONITORING PROGRAM
PRESCRIPTION DRUG MONITORING PROGRAM ST. LOUIS COUNTY Q2 2017 Contents Executive Summary... 2 User Registration & System Utilization... 4 Dispensation Rates... 6 Dispensation Rates by Geography... 6 Dispensation
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 2017 (2017Q3)
NM DRUG OVERDOSE PREVENTION QUARTERLY MEASURES REPORT THIRD QUARTER OF 217 () Substance Abuse Epidemiology Section Prescription Drug Overdose Prevention Program Injury and Behavioral Epidemiology Bureau
OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know
OPIOID OVERDOSE EPIDEMIC: What Healthcare Providers Need to Know WHAT S NEW UPDATE CUMBERLAND, MD Renata J. Henry, M.Ed. Director, Central East ATTC March 16, 2016 Behavioral Health is Essential to Health
The Opioid Epidemic: The State of the State
JOINT LEGISLATIVE COMMITTEE ON HEALTH AND HUMAN SERVICES The Opioid Epidemic: The State of the State Dr. Mandy Cohen, Dr. Susan Kansagra Department of Health and Human Services Nov. 14, 2017 3 PEOPLE DIE
Controlled Substances Board
Controlled Substances Board Report 1 July 1 September 30, 2016 Contact Information Wisconsin Controlled Substances Board Chairperson: Doug Englebert Members: Englebert, Doug, Chairperson Bloom, Alan, Vice
New Guidelines for Prescribing Opioids
New Guidelines for Prescribing Opioids Keeping Your Claimants Safe Presented by: Dr. Mitch Freeman, Pharm.D. Chief Clinical Officer, Pharmacy Solutions Agenda The Opioid Challenge Today How We Got Here
Managed Care Pushes for Safer Opioid Oversight
Page 1 of 6 Clinical AUGUST 11, 2017 Managed Care Pushes for Safer Opioid Oversight High-risk pain Rx eyed Denver Health systems haven t escaped the nation s ongoing opioid crisis, as evidenced by surging
PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018
PRESCRIPTION DRUG MONITORING PROGRAM ST. CHARLES COUNTY Q1 2018 Contents Executive Summary... 2 User Registration & System Utilization... 4 Dispensation Rates... 6 Dispensation Rates by Geography... 6
7/24/2018. Two-Hour Opioid Prescribing Course. Total national filled opioid prescriptions:
Course meets new BME rule. Two-Hour Opioid Prescribing Course Boyde J. Jerry Harrison, MD Steven P. Furr, MD Alabama Board of Medical Examiners June 28, 2018 Total national filled opioid prescriptions:
2012 Medicaid and Partnership Chart
2012 Medicaid and Chart or Alabama $525,000.00 $4,800.00 Minimum: 25,000.00 Alaska $525,000.00 Depends on area of state; Minimum: $113,640 $10,000 in Anchorage $1,656 Minimum:$1838.75 Maximum:$2,841 Minimum:
ANNUAL REPORT
ANNUAL REPORT - 2015 New Hampshire Prescription Drug Monitoring Program Report for July 1, 2014 June 30, 2015 Published October 2015 Table of Contents Executive Summary... 3-4 NH PDMP Background Information
PDMP prescriber use mandates: characteristics, current status, and outcomes in selected states
Prescription Drug Monitoring Program Center of Excellence at Brandeis COE Briefing PDMP prescriber use mandates: characteristics, current status, and outcomes in selected states Revision 3, May 2016* *The
EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC
EMERGENCY DEPARTMENT MODEL PRACTICES DEALING WITH THE PRESCRIPTION OPIOID EPIDEMIC RAMI R KHOURY, MD, FACEP ASSISTANT MEDICAL DIRECTOR EMERGENCY CARE ALLEGIANCE HEALTH ADVERTISING AT ITS BEST! OVERDOSE
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Opioid Analgesics Reference Number: HIM.PA.139 Effective Date: 12.01.17 Last Review Date: 11.17 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the
The Role of the Emergency Department in the Opioid Epidemic. Scott G. Weiner, MD, MPH Department of Emergency Medicine Brigham and Women s Hospital
The Role of the Emergency Department in the Opioid Epidemic Scott G. Weiner, MD, MPH Department of Emergency Medicine Brigham and Women s Hospital Disclosures Treasurer, Massachusetts College of Emergency
Medicare Advantage Outreach and Education Bulletin
Medicare Advantage Outreach and Education Bulletin Blue Cross and Blue Shield of Georgia Prescription Drug Monitoring Programs Prescription drug abuse and diversion are acute problems in the area of pain
North Dakota Board of Pharmacy
North Dakota Board of Pharmacy Updates on Drug Abuse Trends, the PDMP and Medical Marijuana Mark J. Hardy, Pharm D Executive Director Disclosure Statement I have no conflict of interests to report Objectives
See Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: HIM.PA.139 Effective Date: 12.01.17 Last Review Date: 02.18 Line of Business: Health Insurance Marketplace Revision Log See Important Reminder at the end of this policy
Re: Implementation of the Federal Tamper-Resistant Prescription Pad Mandate
January 2, 2008 Ms. Carol Herrmann-Steckel Commissioner Alabama Medicaid Agency PO Box 5624 501 Dexter Avenue Montgomery, AL 36103-5624 Re: Implementation of the Federal Tamper-Resistant Prescription Pad
Aligning Market Objectives and Policy for National Public Health
Abuse-Deterrent Formulations Summit March 7, 2017 Alexandria, Virginia Aligning Market Objectives and Policy for National Public Health Shruti Kulkarni, Esq. Outside Counsel Twitter: @claad_coalition CLAAD
The Morbidity and Mortality of Kansas Drug Epidemic
The Morbidity and Mortality of Kansas Drug Epidemic Fan Xiong, MPH Senior Epidemiologist Kansas Board of Pharmacy Kansas Data-Driven Prevention Initiative Program Kansas Department of Health and Environment,
Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference?
Interventions in Prescription Opioid Abuse Do (or can) Prescription Monitoring Programs Make a Difference? Richard C. Dart, MD, PhD Executive Director of RADARS System, Denver, Colorado Professor, University
Addressing the Opioid Epidemic in Tennessee
Addressing the Opioid Epidemic in Tennessee A Multidisciplinary Approach Melissa McPheeters, PhD, MPH Director, Informatics and Public Health Analytics 26 108 733 *Source: CDC References Centers for
Patient Review and Coordination Program
Patient Review and Coordination Program For Medical Assistance Clients Who Need Assistance In Appropriate Use of Phyllis Coolen, RN, MN Division of Healthcare Health and Recovery Administration January
Opioids drive continued increase in drug overdose deaths
CDC: Drug overdose deaths increase for 11th consecutive year Opioids drive continued increase in drug overdose deaths Atlanta, GA, USA (February 20, 2013) - Drug overdose deaths increased for the 11th
OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES
TITLE 16 CHAPTER 10 PART 14 OCCUPATIONAL AND PROFESSIONAL LICENSING MEDICINE AND SURGERY PRACTITIONERS MANAGEMENT OF PAIN AND OTHER CONDITIONS WITH CONTROLLED SUBSTANCES 16.10.14.1 ISSUING AGENCY: New
Opioid Best Practices
Prevention Partnerships, collaboration and coalition building Focus on youth, adolescent and young adult messaging and services Public information and media campaigns: prevention, education and awareness
Opioid epidemic and PEHP
Opioid epidemic and PEHP Agenda Overview of opioid crisis Utah perspective PEHP: clinical interventions Impact of interventions Why are we here? In the 1990s, the medical establishment came to believe
Kentucky s Plan to Address the Opioid Crisis National Statistics. Scope of the Problem 3/14/18
Kentucky s Plan to Address the Opioid Crisis Dr. Katherine Marks Critical Access Hospital Substance Abuse Summit March 8, 2018 2016 National Statistics Deaths per 100,000 population 25 20 15 10 5 Scope
A nation in pain: Focus on Medicaid
DATA INSIGHTS A nation in pain: Focus on Medicaid Opioid pain medications have become one of the most controversial classes of prescription therapy. While they provide great benefits in controlling both
Pharmacy Law Disclosure Statement. Objectives 6/11/2016. I have no conflicts of interest to disclose related to this presentation.
Pharmacy Law 2016 Ronda H. Lacey, J.D., M.S. Pharm Disclosure Statement I have no conflicts of interest to disclose related to this presentation. Objectives At the conclusion of this continuing education
Drug Overdose in New Mexico
Drug Overdose in New Mexico Behavioral Health Collaborative January 8, 2015 Jim Davis, MA Drug Epidemiologist New Mexico Department of Health Deaths per 100,000 persons 30.0 Drug Overdose Death Rates New
Illinois Prescription Monitoring Program. Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program
Illinois Prescription Monitoring Program Sarah Pointer, Pharm D. Clinical Director of the Illinois Prescription Monitoring Program Agenda Provide an overview of the Illinois Prescription Monitoring Program
Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change
Hydrocodone Combination Analgesic Products Clinical Impact of a Schedule Change Frederick A. Curro D.M.D., Ph.D. Director, PEARL Practice Based Research Network Director, Regulatory Affairs, Bluestone
Kentucky s Strategic Action Plan. Katherine Marks, Ph.D. August 16, 2018
Kentucky s Strategic Action Plan Katherine Marks, Ph.D. August 16, 2018 OUTLINE The state & the need The organization of a response The action plan THE STATE AND THE NEED KENTUCKY 4.4 million people 35
Comprehensive Opioid Abuse Program (COAP) Category 6 Grantees Call
Comprehensive Opioid Abuse Program (COAP) Category 6 Grantees Call BJA Update Tara Kunkel Senior Drug Policy Advisor IPA Bureau of Justice Assistance U.S. Department of Justice Challenges/Lessons Learned
Understanding and Addressing the Public Health Epidemic of Opioid Abuse
Understanding and Addressing the Public Health Epidemic of Opioid Abuse LEWIS S. NELSON, M.D. PROFESSOR AND CHAIR OF EMERGENCY MEDICINE DIRECTOR, DIVISION OF MEDICAL TOXICOLOGY RUTGERS NEW JERSEY MEDICAL
Performance of North Carolina's System for Monitoring Prescription Drug Abuse. Session Law , Section 12F.16.(q)
Performance of North Carolina's System for Monitoring Prescription Drug Abuse Session Law 2015-241, Section 12F.16.(q) Report to the Joint Legislative Oversight Committee on Health and Human Services and
Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic. October 25, 2017
Spotlight on Health Policy Beyond the Clinical: The Opioid Epidemic October 25, 2017 Disclosures and Disclaimer Neither the Institute for Health Policy and Leadership (IHPL) nor I have any relevant financial